Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 26 , ISSUE 1 ( January, 2022 ) > List of Articles


COVID-19-associated Pulmonary Cryptococcosis: A Rare Case Presentation

Suryasnata Das

Keywords : Corticosteroids, COVID-19, Pulmonary cryptococcosis, Uncontrolled diabetes mellitus

Citation Information : Das S. COVID-19-associated Pulmonary Cryptococcosis: A Rare Case Presentation. Indian J Crit Care Med 2022; 26 (1):129-132.

DOI: 10.5005/jp-journals-10071-24084

License: CC BY-NC 4.0

Published Online: 17-01-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Multiple case reports and case series report a surge in opportunistic infections like aspergillosis, mucormycosis, and reactivation of cytomegalovirus infection in coronavirus disease-2019 (COVID-19) patients. We hereby report the first case to the best of our knowledge of pulmonary cryptococcosis in a patient who had successfully recovered from severe COVID-19 illness. The pulmonary cryptococcosis spectrum ranges from asymptomatic infection to frank acute respiratory distress syndrome leading to respiratory failure. Pulmonary cryptococcosis is often underdiagnosed because its clinical presentation, radiographic features, and serologic laboratory investigations are generally inconclusive. The saprophytic colonization of fungus as opposed to invasive disease cannot be assessed from either culture of sputum or currently available serologic tests. Pulmonary cryptococcosis close association with COVID-19 can be further established with reporting of more cases. Hereby, we propose the term CAPC (COVID-19-associated pulmonary cryptococcosis) for such cases.

  1. Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis 2020;2020:S1473309920308471. DOI: 10.1016/S1473-3099(20)30847-1.
  2. Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A, et al. Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia 2021;186(2):289–298. DOI: 10.1007/s11046-021-00528-2. PMID: 33544266; PMCID: PMC7862973.
  3. Carll WC, Rady MY, Salomao MA, Patel B, Singh VP, Sen A. Cytomegalovirus haemorrhagic enterocolitis associated with severe infection with COVID-19. BMJ Open Gastroenterol 2021;8:e000556. DOI: 10.1136/bmjgast-2020-000556.
  4. Setianingrum F, Rautemaa-Richardson R, Denning DW. Pulmonary cryptococcosis: a review of pathobiology and clinical aspects. Med Mycol 2019;57(2):133–150. DOI: 10.1093/mmy/myy086. PMID: 30329097.
  5. Yu JQ, Tang KJ, Xu BL, Xie CM, Light RW. Pulmonary cryptococcosis in non-AIDS patients. Braz J Infect Dis 2012;16(6):531–539. DOI: 10.1016/j.bjid.2012.07.004. PMID: 23154046.
  6. Hansell DM, Armstrong P, Lynch DA, Page McAdams H. Imaging of diseases of the chest. 4th ed. Philadelphia: Mosby/Elsevier; 2005.
  7. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2010;50(3):291–322. DOI: 10.1086/649858. PMID: 20047480; PMCID: PMC5826644.
  8. Patel A, Agarwal R, Rudramurthy SM, Shevkani M, Xess I, Sharma R, et al; MucoCovi Network. Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India. Emerg Infect Dis 2021;27(9):2349–2359. DOI: 10.3201/eid2709. 210934.
  9. Al-Tawfiq JA, Alhumaid S, Alshukairi AN, Temsah MH, Barry M, Al Mutair A, et al. COVID-19 and mucormycosis superinfection: the perfect storm. Infection 2021;49(5):1–21. DOI: 10.1007/s15010- 021-01670-1. PMID: 34302291; PMCID: PMC8302461.
  10. Khatib MY, Ahmed AA, Shaat SB, Mohamed AS, Nashwan AJ. Cryptococcemia in a patient with COVID-19: a case report. Clin Case Rep 2020;9(2):853–855. DOI: 10.1002/ccr3.3668. PMID: 33598258; PMCID: PMC7869327.
  11. Ghanem H, Sivasubramanian G. Cryptococcus neoformans meningoencephalitis in an immunocompetent patient after COVID-19 infection. Case Rep Infect Dis 2021;2021:5597473. DOI: 10.1155/2021/5597473.
  12. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 2020;71(15):762–768. DOI: 10.1093/cid/ciaa248. PMID: 32161940; PMCID: PMC7108125.
  13. Liu J, Li S, Liu J, Liang B, Wang X, Wang H, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine 2020;55:102763. DOI: 10.1016/j.ebiom.2020.102763.
  14. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 2020;130(5):2620–2629. DOI: 10.1172/JCI137244. PMID: 32217835; PMCID: PMC7190990.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.